| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |